āĻšā§āĻŽQDI âĸ FRA
add
Quest Diagnostics Inc
ā§§ā§ā§Ž.ā§Ļā§ĢâŦ
⧍⧠āĻĢā§āĻŦ, ā§§ā§Ļ:ā§Ģ⧝:ā§Ēā§Š PM GMT +ā§§ · EUR · FRA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§ā§ā§Ģ.ā§§ā§ĻâŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§ā§ā§Ž.ā§Ļā§ĢâŦ - ā§§ā§ā§Ž.ā§Ļā§ĢâŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§ā§Šā§¯.ā§Žā§ĢâŦ - ā§§ā§ā§Ž.ā§Ļā§ĢâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧍.ā§Šā§ŠāĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Š.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NYSE
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§¨ā§Žā§Ļ.ā§Ŧā§Ļ āĻā§ | ā§.ā§Ļā§Ŧ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ģ⧍.⧍ā§Ļ āĻā§ | ā§Ē.ā§Žā§¨% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧍ā§Ē.ā§Ģā§Ļ āĻā§ | ā§§ā§Ļ.ā§Šā§Ŧ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§Ž.ā§ā§Š | ā§Š.ā§Ļā§% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ⧍.ā§Ē⧍ | ā§Ž.ā§Ģ⧍% |
EBITDA | ā§Ģā§Š.ā§ā§Ļ āĻā§ | ā§Ŧ.ā§ā§Ŧ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍ā§Ē.ā§Ļā§Ē% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Ē⧍.ā§Ļā§Ļ āĻā§ | -ā§¨ā§Š.ā§Ģā§Ļ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§.ā§Ŧ⧍āĻļāĻ¤Â āĻā§ | ā§Ļ.ā§Ēā§Ģ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Žā§¯ā§Š.⧝ā§Ļ āĻā§ | -ā§Š.ā§Ēā§Ē% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§ā§¨ā§Ž.ā§Ŧā§Ļ āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§§.ā§Ļā§Ļ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ⧍.ā§Ŧ⧝ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ŧ.ā§Ļā§Ģ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§.ā§§ā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧍ā§Ē.ā§Ģā§Ļ āĻā§ | ā§§ā§Ļ.ā§Šā§Ŧ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Ēā§Ŧ.ā§Ģā§Ļ āĻā§ | ā§Ļ.⧍⧍% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧧⧝.ā§§ā§Ļ āĻā§ | ā§Ŧā§§.⧝ā§Ģ% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§¨ā§Ž.ā§ā§Ļ āĻā§ | -ā§Ŧā§Ž.ā§Žā§¨% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§§.⧍ā§Ļ āĻā§ | ⧝ā§Ē.ā§Ē⧍% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§Šā§Ē.⧝ā§Ļ āĻā§ | ⧧⧧⧝.ā§Ģā§Ļ% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧝ā§Ŧā§
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Ģā§,ā§Ļā§Ļā§Ļ